BioCentury
ARTICLE | Clinical News

Luminate: Phase II started

June 15, 2015 7:00 AM UTC

Allegro began a double-blind, placebo-controlled, international Phase II trial to evaluate 1, 2 or 3 mg intravitreal Luminate given at days 0, 30 and 60 in 100 patients. ...